366 related articles for article (PubMed ID: 26386570)
1. Risk factors and serological markers of liver cirrhosis after Fontan procedure.
Shimizu M; Miyamoto K; Nishihara Y; Izumi G; Sakai S; Inai K; Nishikawa T; Nakanishi T
Heart Vessels; 2016 Sep; 31(9):1514-21. PubMed ID: 26386570
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
[TBL] [Abstract][Full Text] [Related]
3. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study.
Schwartz MC; Sullivan L; Cohen MS; Russo P; John AS; Guo R; Guttenberg M; Rand EB
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):904-9. PubMed ID: 21955477
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure.
Ginde S; Hohenwalter MD; Foley WD; Sowinski J; Bartz PJ; Venkatapuram S; Weinberg C; Tweddell JS; Earing MG
Congenit Heart Dis; 2012; 7(3):235-42. PubMed ID: 22360766
[TBL] [Abstract][Full Text] [Related]
5. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes.
Wu FM; Jonas MM; Opotowsky AR; Harmon A; Raza R; Ukomadu C; Landzberg MJ; Singh MN; Valente AM; Egidy Assenza G; Perez-Atayde AR
J Heart Lung Transplant; 2015 Jul; 34(7):883-91. PubMed ID: 25863891
[TBL] [Abstract][Full Text] [Related]
6. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
[TBL] [Abstract][Full Text] [Related]
7. Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.
Hayashi T; Inuzuka R; Shindo T; Hirata Y; Shimizu N; Oka A
Pediatr Cardiol; 2014 Apr; 35(4):608-15. PubMed ID: 24163010
[TBL] [Abstract][Full Text] [Related]
8. Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.
Izumi G; Takeda A; Yamazawa H; Sasaki O; Kato N; Asai H; Tachibana T; Matsui Y
Heart Vessels; 2020 Apr; 35(4):586-592. PubMed ID: 31562553
[TBL] [Abstract][Full Text] [Related]
9. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors.
Baek JS; Bae EJ; Ko JS; Kim GB; Kwon BS; Lee SY; Noh CI; Park EA; Lee W
Heart; 2010 Nov; 96(21):1750-5. PubMed ID: 20956491
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study.
Goldberg DJ; Surrey LF; Glatz AC; Dodds K; O'Byrne ML; Lin HC; Fogel M; Rome JJ; Rand EB; Russo P; Rychik J
J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446492
[TBL] [Abstract][Full Text] [Related]
11. Fontan circulation over 30 years. What should we learn from those patients?
Sakamoto T; Nagashima M; Hiramatsu T; Matsumura G; Park IS; Yamazaki K
Asian Cardiovasc Thorac Ann; 2016 Oct; 24(8):765-771. PubMed ID: 27563102
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation.
Surrey LF; Russo P; Rychik J; Goldberg DJ; Dodds K; O'Byrne ML; Glatz AC; Rand EB; Lin HC
Hum Pathol; 2016 Nov; 57():106-115. PubMed ID: 27476041
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for liver complications after the Fontan procedure.
Hilscher MB; Johnson JN; Cetta F; Driscoll DJ; Poterucha JJ; Sanchez W; Connolly HM; Kamath PS
Congenit Heart Dis; 2017 Mar; 12(2):124-132. PubMed ID: 28140526
[TBL] [Abstract][Full Text] [Related]
14. Lymphopenia in Patients with Single-ventricle Heart Disease after the Fontan Operation.
Mattes M; Connor J; Kelly SS; Schwartz MC
Congenit Heart Dis; 2016 May; 11(3):270-5. PubMed ID: 26554755
[TBL] [Abstract][Full Text] [Related]
15. Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure - A Nationwide Survey in Japan.
Kuwabara M; Niwa K; Toyoda T; Shirai T; Tateno S; Ohuchi H; Tanaka Y; Ichida F; Fujisawa T; Akagi T; Mori Y;
Circ J; 2018 Mar; 82(4):1155-1160. PubMed ID: 29445059
[TBL] [Abstract][Full Text] [Related]
16. Hepatic pathology after Fontan palliation: spectrum of imaging findings.
Wallihan DB; Podberesky DJ
Pediatr Radiol; 2013 Mar; 43(3):330-8. PubMed ID: 23052733
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Fontan liver disease: Correlation of transjugular liver biopsy with magnetic resonance and hemodynamics.
Silva-Sepulveda JA; Fonseca Y; Vodkin I; Vaughn G; Newbury R; Vavinskaya V; Dwek J; Perry JC; Reshamwala P; Baehling C; Lyon J; Davis C; Lee JW; El-Sabrout H; Shahbah D; Alshawabkeh L; Moore JW; El-Said H
Congenit Heart Dis; 2019 Jul; 14(4):600-608. PubMed ID: 31038848
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.
Friedrich-Rust M; Koch C; Rentzsch A; Sarrazin C; Schwarz P; Herrmann E; Lindinger A; Sarrazin U; Poynard T; Schäfers HJ; Zeuzem S; Abdul-Khaliq H
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):560-7. PubMed ID: 18329470
[TBL] [Abstract][Full Text] [Related]
19. Liver Disease in Patients After the Fontan Operation.
Pundi K; Pundi KN; Kamath PS; Cetta F; Li Z; Poterucha JT; Driscoll DJ; Johnson JN
Am J Cardiol; 2016 Feb; 117(3):456-60. PubMed ID: 26704027
[TBL] [Abstract][Full Text] [Related]
20. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
